A Versatile Model of Microfluidic Perifusion System for the Evaluation of C-Peptide Secretion Profiles: Comparison Between Human Pancreatic Islets and HLSC-Derived Islet-Like Structures.

C-peptide HLSC-ILS T2DM human pancreatic islets microfluidic obese perifusion

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
07 Feb 2020
Historique:
received: 29 01 2020
accepted: 05 02 2020
entrez: 13 2 2020
pubmed: 13 2 2020
medline: 13 2 2020
Statut: epublish

Résumé

A robust and easy-to-use tool for the ex vivo dynamic evaluation of pancreatic islet (PI) function is essential for further development of novel cell-based therapeutic approaches to treating diabetes. Here, we developed four different glucose perifusion protocols (GPPs) in a microfluidic perifusion system (MPS), based entirely on commercially available components. After validation, the GPPs were used to evaluate C-peptide secretion profiles of PIs derived from different donors (healthy, obese, and type 2 diabetic) and from human liver stem-cell-derived islet-like structures (HLSC-ILS). Using this device, we demonstrated that PIs derived from healthy donors displayed a physiological C-peptide secretion profile as characterized by the response to (a) different glucose concentrations, (b) consecutive pulses of high-glucose concentrations, (c) a glucose threshold ranging from 5-8 mM, and (d) a constant high-glucose perifusion in a biphasic manner. Moreover, we were able to detect a dysregulated secretion profile in PIs derived from both obese and type 2 diabetes mellitus (T2DM) donors. Finally, we also evaluated the kinetic secretion profiles of HLSC-ILS, demonstrating that, nonetheless, with a lower amplitude of secretion compared to PI derived from healthy donors, they were already glucose-responsive on day seven post-differentiation. In conclusion, we have provided evidence that our MPS is a versatile device and may represent a valuable tool to study insulin-producing cells in vitro.

Identifiants

pubmed: 32046184
pii: biomedicines8020026
doi: 10.3390/biomedicines8020026
pmc: PMC7168272
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Unicyte (Oberdorf NW, Switzerland)
ID : Reg2019

Déclaration de conflit d'intérêts

Y.G. and C.T are employed by a commercial company (Unicyte AG) and contributed to the study as researcher. Y.G., V.N.-T., C.T., and G.C are named inventors in related patents. G.C. is a component of the scientific advisory board of Unicyte AG. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Stem Cell Rev Rep. 2019 Feb;15(1):93-111
pubmed: 30191384
Matrix Biol. 2020 Jan;85-86:205-220
pubmed: 31238092
Diabetes. 2005 Mar;54(3):727-35
pubmed: 15734849
J Clin Invest. 1996 Dec 15;98(12):2805-12
pubmed: 8981928
Annu Rev Anal Chem (Palo Alto Calif). 2016 Jun 12;9(1):249-69
pubmed: 27306310
Stem Cell Reports. 2019 Feb 12;12(2):351-365
pubmed: 30661993
Islets. 2011 Sep-Oct;3(5):284-90
pubmed: 21811103
Anal Chem. 2009 Aug 15;81(16):6837-42
pubmed: 19621896
Lab Chip. 2015 Feb 7;15(3):823-32
pubmed: 25474044
J Tissue Eng Regen Med. 2017 Mar;11(3):887-895
pubmed: 25619945
J Clin Invest. 1992 Oct;90(4):1263-8
pubmed: 1401063
Diabetes. 1972 Oct;21(10):987-98
pubmed: 4561331
Lab Chip. 2016 Feb 7;16(3):409-31
pubmed: 26732665
Diabetes. 1967 Jan;16(1):35-9
pubmed: 5333500
J Clin Invest. 2011 Jun;121(6):2118-25
pubmed: 21633180
Cell Transplant. 2008;16(10):1039-48
pubmed: 18351020
Diabetes. 2016 Feb;65(2):438-50
pubmed: 26307586
Physiol Rev. 1980 Apr;60(2):442-509
pubmed: 6247727
Endocrinology. 1968 Sep;83(3):572-84
pubmed: 4877098
Endocrinology. 1947 Feb;40(2):92-7
pubmed: 20286606
Lab Chip. 2017 Feb 28;17(5):772-781
pubmed: 28157238
ALTEX. 2010;27(2):105-13
pubmed: 20686743

Auteurs

Yonathan Gomez (Y)

Unicyte AG, Molecular Biotechnology Center (MBC), University of Turin. Via Nizza, 52, 10126 Turin, Italy.

Victor Navarro-Tableros (V)

i3T Società per la Gestione Dell'incubatore di Imprese e per il Trasferimento Tecnologico Scarl, University of Turin, 10126 Turin, Italy.

Ciro Tetta (C)

Unicyte AG, Unicyte srl, Via Lugaro, 15, 10100 Turin, Italy.

Giovanni Camussi (G)

Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy.

Maria Felice Brizzi (MF)

Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy.

Classifications MeSH